Nalaganje...
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
At present, there are no proven agents for treatment of coronavirus disease (COVID-19). The available evidence has not allowed guidelines to clearly recommend any drugs outside the context of clinical trials. The novel coronavirus SARS-CoV-2 that causes COVID-19 invokes a hyperinflammatory state dri...
Shranjeno v:
| izdano v: | Pharmaceut Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292936/ https://ncbi.nlm.nih.gov/pubmed/32535732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40290-020-00342-z |
| Oznake: |
Označite
Brez oznak, prvi označite!
|